Payments to Acquire Property, Plant, and Equipment of ALNYLAM PHARMACEUTICALS, INC. from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
ALNYLAM PHARMACEUTICALS, INC. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • ALNYLAM PHARMACEUTICALS, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $8,970,000, a 31% decline year-over-year.
  • ALNYLAM PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $58,697,000, a 71% increase from 2024.
  • ALNYLAM PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $34,277,000, a 45% decline from 2023.
  • ALNYLAM PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $62,211,000, a 14% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

ALNYLAM PHARMACEUTICALS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $58,697,000 +$24,420,000 +71% 01 Jan 2025 31 Dec 2025 10-K 12 Feb 2026 2025 FY
2024 $34,277,000 -$27,934,000 -45% 01 Jan 2024 31 Dec 2024 10-K 12 Feb 2026 2025 FY
2023 $62,211,000 -$9,848,000 -14% 01 Jan 2023 31 Dec 2023 10-K 12 Feb 2026 2025 FY
2022 $72,059,000 -$4,313,000 -5.6% 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025 2024 FY
2021 $76,372,000 +$6,011,000 +8.5% 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
2020 $70,361,000 -$69,795,000 -50% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $140,156,000 +$13,269,000 +10% 01 Jan 2019 31 Dec 2019 10-K 10 Feb 2022 2021 FY
2018 $126,887,000 +$22,678,000 +22% 01 Jan 2018 31 Dec 2018 10-K 11 Feb 2021 2020 FY
2017 $104,209,000 +$39,652,000 +61% 01 Jan 2017 31 Dec 2017 10-K 13 Feb 2020 2019 FY
2016 $64,557,000 +$51,607,000 +399% 01 Jan 2016 31 Dec 2016 10-K 14 Feb 2019 2018 FY
2015 $12,950,000 +$3,989,000 +45% 01 Jan 2015 31 Dec 2015 10-K 15 Feb 2018 2017 FY
2014 $8,961,000 +$4,955,000 +124% 01 Jan 2014 31 Dec 2014 10-K 15 Feb 2017 2016 FY
2013 $4,006,000 -$4,342,000 -52% 01 Jan 2013 31 Dec 2013 10-K 12 Feb 2016 2015 FY
2012 $8,348,000 +$7,057,000 +547% 01 Jan 2012 31 Dec 2012 10-K 13 Feb 2015 2014 FY
2011 $1,291,000 -$3,441,000 -73% 01 Jan 2011 31 Dec 2011 10-K 20 Feb 2014 2013 FY
2010 $4,732,000 01 Jan 2010 31 Dec 2010 10-K 19 Feb 2013 2012 FY

ALNYLAM PHARMACEUTICALS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $8,970,000 -$4,003,000 -31% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $12,973,000 -$918,000 -6.6% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $13,891,000 -$3,968,000 -22% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $17,859,000 +$681,000 +4% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $17,178,000 -$2,439,000 -12% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q1 2020 $19,617,000 -$24,432,000 -55% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q1 2019 $44,049,000 +$22,792,000 +107% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $21,257,000 -$14,895,000 -41% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q1 2017 $36,152,000 +$33,393,000 +1210% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q1 2016 $2,759,000 +$649,000 +31% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q1 2015 $2,110,000 +$1,722,000 +444% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q1 2014 $388,000 -$1,411,000 -78% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015 2015 Q1
Q1 2013 $1,799,000 +$1,536,000 +584% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1
Q1 2012 $263,000 +$235,000 +839% 01 Jan 2012 31 Mar 2012 10-Q 07 May 2013 2013 Q1
Q1 2011 $28,000 -$1,069,000 -97% 01 Jan 2011 31 Mar 2011 10-Q 03 May 2012 2012 Q1
Q1 2010 $1,097,000 01 Jan 2010 31 Mar 2010 10-Q 05 May 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.